Mees lines and Beau lines after chemotherapy.
Huang
Tzu-Chuan
TC
Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Chao
Tsu-Yi
TY
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003561:Cytarabine / Q000009:adverse effects*; D003630:Daunorubicin / Q000009:adverse effects*; D000077143:Docetaxel; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D009260:Nail Diseases / Q000139:chemically induced*; D043823:Taxoids / Q000009:adverse effects*
D043823:Taxoids; D003561:Cytarabine; D000077143:Docetaxel; D003630:Daunorubicin